Sukjun Kim

4PUBLICATIONS
55CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Software quality, processes and metricsMicrobial genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Mar 08, 2024
A Phase II Open-Label Randomized Clinical Trial of Preoperative Durvalumab or Durvalumab plus Tremelimumab in Resectable Head and Neck Squamous Cell Carcinoma.

Chang Gon Kim, Min Hee Hong, Dahee Kim

|Aug 26, 2021
A high-resolution temporal atlas of the SARS-CoV-2 translatome and transcriptome.

Doyeon Kim, Sukjun Kim, Joori Park

|Aug 21, 2021
The regulatory impact of RNA-binding proteins on microRNA targeting.

Sukjun Kim, Soyoung Kim, Hee Ryung Chang

Pageof 1